Parental Disapproval Contributes to Racial/Ethnic Differences in Prescription Drug Misuse by Teens, Reports Journal of Developmental & Behavioral Pediatrics
Study Looks at Cultural Factors Underlying Racial/Ethnic Variation
Source Newsroom: Wolters Kluwer Health: Lippincott Williams and Wilkins
Newswise — Philadelphia, Pa. (May 12, 2014) – Parents' attitudes toward substance use may help to explain observed racial/ethnic variations in prescription drug misuse among teens, reports a study in the May Journal of Developmental & Behavioral Pediatrics, the official journal of the Society for Developmental and Behavioral Pediatrics. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.
"Our findings add support to growing evidence that parents continue to remain a vital part of adolescents' decision-making, particularly regarding potentially risky behaviors," according to the new research by Brigid M. Conn, MA, and Amy K. Marks, PhD, of Suffolk University, Boston.
Parent Disapproval Linked to Lower Rate of Drug Misuse
The researchers analyzed data on prescription drug misuse from a national survey of more than 18,000 adolescents. "Misuse and abuse of prescription drugs is one of the fastest growing drug epidemics in the United States," the researchers write.
As in previous studies, Caucasian teens had the highest rates of prescription drug misuse. For example, 3.4 percent of Caucasian adolescents misused tranquilizers, compared to 2.9 percent of Hispanic and 0.9 percent of African American youth.
In contrast to previous studies, teens from higher-income families had lower rates of prescription drug misuse. Rates were also higher in older adolescents, and in girls compared to boys.
The teens were also asked about their parents' and peers' attitudes toward specific types of substance use. Parental disapproval was associated with lower rates of prescription drug misuse—although this effect varied by race/ethnicity. Even though Caucasian teens had the highest rates of prescription drug misuse, those whose parents strongly disproved of all types of substance use were at lower risk than teens in the two minority groups.
Strong parental disapproval of alcohol use was linked to lower rates of prescription drug misuse in African American teens, while parental disapproval of marijuana use was a stronger factor for Hispanic teens. Dr. Marks comments, "No matter what the ethnic/racial background of the family, parents' disapproving attitudes about misusing substances in general—whether alcohol, marijuana, or tobacco—play a strong role in protecting their adolescents from misusing prescription medicine."
Step toward Understanding 'Culture-Specific' Factors in Substance Abuse
Caucasian teens whose close friends disapproved of substance use had lower rates of prescription drug misuse, although peer attitudes had little impact for African American or Hispanic teens. Dr. Marks adds, "Parents can also help their adolescents navigate toward friends with shared substance use disapproval attitudes."
The study confirms racial/ethnic variations in substance use by adolescents. It also provides initial evidence that disapproval by "important socialization agents"—especially parents—has a significant effect on prescription drug misuse.
That result may provide clues as to how the racial/ethnic variations arise. Past studies of substance use in teens have typically used race as an "explanation" for observed differences.
More recently, researchers are focusing on values and other "culture-specific factors" that may explain risk behaviors, rather than generalizing across groups. "We're already working on new studies to understand some of the unique socializing factors or agents which seem to be protective for Hispanic and African American adolescents, beyond parental disapproval," says Dr Marks.
She adds, "As we learn more about what kinds of socializing messages matter most to which cultural groups, clinicians, teachers, social workers, and parents alike can help keep steering their adolescents in meaningful ways to make healthy behavioral choices when it comes to prescription drugs."
# # #
About the Journal of Developmental & Behavioral Pediatrics
Written for physicians, clinicians, psychologists and researchers, each issue of the Journal of Developmental & Behavioral Pediatrics (www.jrnldbp.com) is devoted entirely to the developmental and psychosocial aspects of pediatric health care. Each issue brims with original articles, case reports, challenging cases and reviews—the latest work of many of today's best known leaders in related fields—that help professionals across disciplines stay current with the latest information in the field. Relevant areas covered include learning disorders, developmental disabilities, and emotional, behavioral, and psychosomatic problems. Journal of Developmental & Behavioral Pediatrics is the official journal of the Society for Developmental and Behavioral Pediatrics.
About Wolters Kluwer Health
Wolters Kluwer Health is a leading global provider of information, business intelligence and point-of-care solutions for the healthcare industry. Serving more than 150 countries and territories worldwide, Wolters Kluwer Health’s customers include professionals, institutions and students in medicine, nursing, allied health and pharmacy. Major brands include Health Language®, Lexicomp®, Lippincott Williams & Wilkins, Medicom®, Medknow, Ovid®, Pharmacy OneSource®, ProVation® Medical and UpToDate®.
Wolters Kluwer Health is part of Wolters Kluwer, a market-leading global information services company. Wolters Kluwer had 2012 annual revenues of €3.6 billion ($4.6 billion), employs approximately 19,000 people worldwide, and maintains operations in over 40 countries across Europe, North America, Asia Pacific, and Latin America. Follow our official Twitter handle: @WKHealth.